Dimitrios Mantzilas

Rackspace MailGun Outlook Microsoft Office 365 Mobile Friendly Typekit Google Tag Manager

biotechnologies targeted radionuclide therapy oncology camel derived antibodies radiopharmaceuticals biotechnology research precision radiopharmaceuticals targeted radiotherapy camelid single-domain antibodies fibroblast activation protein fap-targeted therapy alpha-emitting radionuclides theranostic radiopharmaceuticals pipeline development combination therapies isotope research clinical studies tumor-targeting technology monoclonal antibodies radiometal labeling high affinity sdabs cancer treatment innovation phase i clinical trials radiolabeling procedures academic access program gmp grade sdab treatment personalization molecular imaging patient-specific dosimetry radiation safety tumor retention bystander effects development timelines cancer imaging therapeutic index optimization radiopharmaceutical development drug delivery oncology solutions high target specificity broad-spectrum radiotherapy research collaborations investigator-initiated trials radionuclide therapy diagnostic isotopes fast tissue penetration multidisciplinary team immune system involvement oncology clinical trials advanced preclinical studies cancer patient care collaborative innovation healthcare equity biotechnology advancement medical partnerships transformative cancer therapies hospital & health care